(No ratings)
Dr. Leslie Elaine Lehmann, MD is a pediatric oncologist in BOSTON, MA specializing in pediatric hematology/oncology. She graduated from Duke University School of Medicine. Dr. Leslie Elaine Lehmann, MD is affiliated with Dana-Farber Cancer Institute and Children's Hospital.
Dr. Leslie Elaine Lehmann, MD graduated from Duke University School of Medicine. She completed residency at Duke University Medical Center. She is certified by the Board Certification:Pediatric Hematology/Oncology and has a state license in Massachusetts.
Medical School: Duke University School of Medicine
Residency: Duke University Medical Center
Board Certification: Board Certification:Pediatric Hematology/Oncology
Licensed In: Massachusetts
Dr. Leslie Elaine Lehmann, MD does not have any reviews yet, be the first to leave a review of Dr. Leslie Elaine Lehmann, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Leslie Elaine Lehmann, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Vertex Pharmaceuticals Incorporated |
$16,792
CASGEVY $8,318 |
$8,475 |
|---|---|---|
| Shire North American Group Inc |
$6,129
$6,129 |
|
| bluebird bio, Inc. |
$2,799
Zynteglo $2,720 |
$79 |
| Takeda Pharmaceuticals U.S.A., Inc. |
$1,775
$1,775 |
|
| Jazz Pharmaceuticals Inc. |
$1,276
Defitelio $1,276 |
|
| Other |
$1,222
LYFGENIA $419 |
$803 |
| Consulting Fee | $27,189 |
|---|---|
| Travel and Lodging | $1,831 |
| Food and Beverage | $975 |
Dr. Leslie Elaine Lehmann, MD has received 5 research payments totaling $58,552.
Dr Lehmann attended Harvard College and received her MD from Duke University Medical School, where, after finishing a pediatric residency, she spent a year as chief resident. She completed a pediatric hematology-oncology fellowship at DFCI/Children's Hospital Boston in 1996 and subsequently joined the faculty. In 1998, she became medical director of the Pediatric Transplant Unit at Children's Hospital and, in 2007, was appointed clinical director of the Pediatric Stem Cell Transplant Program.